Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for COLL

Stock Name	Collegium Pharmaceutical Inc
Ticker	COLL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US19459J1043
LEI	54930049FXZMTLW8D496

Show aggregate COLL holdings

News associated with COLL

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at HC Wainwright: HC Wainwright upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) to a strong-buy rating in a report released on Monday morning, MarketBeat Ratings reports. The firm currently has $44.00 target price on the specialty pharmaceutical company’s stock. COLL has been the subject of several other reports. Wall Street Zen upgraded Collegium Pharmaceutical from a […] - 2025-08-14 03:00:52
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by Wall Street Zen: Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday. Separately, Piper Sandler reissued a “neutral” rating and set a $37.00 price objective (up previously from $36.00) on shares of Collegium Pharmaceutical […] - 2025-08-11 04:33:01
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH: Universal Beteiligungs und Servicegesellschaft mbH lifted its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 124,671 shares of the specialty pharmaceutical company’s stock after purchasing an additional 2,895 […] - 2025-07-29 05:22:58
Victory Capital Management Inc. Sells 60,823 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Victory Capital Management Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 10.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 498,713 shares of the specialty pharmaceutical company’s stock after selling 60,823 shares during the quarter. Victory Capital […] - 2025-07-24 04:53:18
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon Corp: Bank of New York Mellon Corp decreased its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.1% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 242,261 shares of the specialty pharmaceutical company’s stock after selling 10,426 shares during the period. Bank of New York Mellon Corp’s holdings in Collegium Pharmaceutical were […] - 2025-07-23 04:42:46
Collegium Pharmaceutical (NASDAQ:COLL) to Repurchase $150.00 million in Outstanding Stock: Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) announced that its Board of Directors has approved a stock repurchase program on Monday, July 7th, RTT News reports. The company plans to buyback $150.00 million in outstanding shares. This buyback authorization allows the specialty pharmaceutical company to repurchase up to 15.4% of its shares through open market […] - 2025-07-09 02:16:45
Collegium Pharmaceutical Breaks Above 200-Day Moving Average - Bullish for COLL: In trading on Monday, shares of Collegium Pharmaceutical Inc (Symbol: COLL) crossed above their 200 day moving average of $31.15, changing hands as high as $31.83 per share. Collegium Pharmaceutical Inc shares are currently trading up about 4.2% on the day. The chart below sho - 2025-07-07 12:54:17
Principal Financial Group Inc. Sells 71,695 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Principal Financial Group Inc. decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,573,356 shares of the specialty pharmaceutical company’s stock after selling 71,695 shares during the quarter. Principal […] - 2025-07-07 05:54:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Illinois Municipal Retirement Fund: Illinois Municipal Retirement Fund lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,820 shares of the specialty pharmaceutical company’s stock after selling 1,384 shares during the quarter. Illinois Municipal Retirement Fund’s […] - 2025-07-04 05:19:14
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ritholtz Wealth Management: Ritholtz Wealth Management lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 5.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 32,108 shares of the specialty pharmaceutical company’s stock after selling 1,676 shares during the quarter. Ritholtz Wealth Management’s holdings in Collegium Pharmaceutical were worth $958,000 as of its most […] - 2025-06-18 05:56:50
Exchange Traded Concepts LLC Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Exchange Traded Concepts LLC cut its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 16.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 62,426 shares of the specialty pharmaceutical company’s stock after selling 12,669 shares during […] - 2025-06-18 05:18:59
Farther Finance Advisors LLC Raises Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Farther Finance Advisors LLC boosted its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 11,091 shares of the specialty pharmaceutical company’s stock after acquiring an additional 477 shares during the period. Farther Finance Advisors LLC’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-18 04:30:54
California State Teachers Retirement System Has $862,000 Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): California State Teachers Retirement System reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 30,093 shares of the specialty pharmaceutical company’s stock after selling 856 shares during the period. California State Teachers Retirement System’s holdings in Collegium Pharmaceutical were […] - 2025-06-11 05:04:51
Wellington Management Group LLP Lowers Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Wellington Management Group LLP reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 22.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 88,591 shares of the specialty pharmaceutical company’s stock after selling 26,049 shares during the period. Wellington Management Group […] - 2025-06-06 05:04:54
Bank of America Corp DE Trims Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Bank of America Corp DE decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 29.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 86,096 shares of the specialty pharmaceutical company’s stock after selling 36,093 shares during the period. Bank of America Corp DE’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-02 04:38:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by ProShare Advisors LLC: ProShare Advisors LLC boosted its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 28.8% in the 4th quarter, Holdings Channel reports. The fund owned 11,196 shares of the specialty pharmaceutical company’s stock after acquiring an additional 2,506 shares during the quarter. ProShare Advisors LLC’s holdings in Collegium Pharmaceutical were worth $321,000 […] - 2025-05-30 05:06:52
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $43.80 Average Price Target from Brokerages: Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price […] - 2025-05-21 03:14:51
Voya Investment Management LLC Cuts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Voya Investment Management LLC lessened its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,923 shares of the specialty pharmaceutical company’s stock after selling 789 shares during the period. Voya […] - 2025-05-13 04:32:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stake Reduced by Hsbc Holdings PLC: Hsbc Holdings PLC decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 3.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 16,879 shares of the specialty pharmaceutical company’s stock after selling 576 shares during the period. Hsbc Holdings PLC’s holdings in Collegium Pharmaceutical were worth $483,000 at the end […] - 2025-05-07 05:00:51
Barclays PLC Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Barclays PLC increased its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 6.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,754 shares of the specialty pharmaceutical company’s stock after purchasing an additional 4,702 shares during the […] - 2025-05-01 05:14:59
Raymond James Financial Inc. Buys New Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Raymond James Financial Inc. bought a new stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 84,883 shares of the specialty pharmaceutical company’s stock, valued at approximately $2,432,000. Other hedge funds and […] - 2025-04-30 05:10:55
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Legal & General Group Plc: Legal & General Group Plc lessened its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 1.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 91,309 shares of the specialty pharmaceutical company’s stock after selling 1,084 shares during the period. Legal & General Group Plc’s holdings in Collegium Pharmaceutical were […] - 2025-04-24 06:31:01
Russell Investments Group Ltd. Decreases Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Russell Investments Group Ltd. reduced its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 31.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,649 shares of the specialty pharmaceutical company’s stock after selling 6,223 shares […] - 2025-04-24 04:48:48
JPMorgan Chase & Co. Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): JPMorgan Chase & Co. lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 70.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 82,691 shares of the specialty pharmaceutical company’s stock after selling 194,513 shares during the […] - 2025-04-24 04:16:59
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to Buy at StockNews.com: Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other analysts also recently weighed in on the stock. Needham & Company LLC reissued a “buy” rating and set a […] - 2025-04-21 02:22:45
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Invesco Ltd.: Invesco Ltd. grew its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 19.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,775,760 shares of the specialty pharmaceutical company’s stock after acquiring an additional 289,335 shares during the quarter. Invesco Ltd. owned about […] - 2025-04-16 04:47:00
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at StockNews.com: StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research report report published on Friday morning. A number of other equities research analysts also recently weighed in on COLL. Needham & Company LLC reaffirmed a “buy” rating and issued a $46.00 target price on […] - 2025-04-14 02:58:57
Vanguard Group Inc. Sells 63,876 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Vanguard Group Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,282,666 shares of the specialty pharmaceutical company’s stock after selling 63,876 shares during the period. Vanguard Group Inc. […] - 2025-04-11 06:16:58
Corebridge Financial Inc. Sells 1,595 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Corebridge Financial Inc. lowered its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.5% during the 4th quarter, HoldingsChannel reports. The fund owned 17,084 shares of the specialty pharmaceutical company’s stock after selling 1,595 shares during the period. Corebridge Financial Inc.’s holdings in Collegium Pharmaceutical were worth $489,000 as of its […] - 2025-04-09 04:38:48
American Century Companies Inc. Has $2.45 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL): American Century Companies Inc. trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 18.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,466 shares of the specialty pharmaceutical company’s stock after selling 19,447 […] - 2025-04-08 05:04:48

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) COLL holdings

Date	Number of COLL Shares Held	Base Market Value of COLL Shares	Local Market Value of COLL Shares	Change in COLL Shares Held	Change in COLL Base Value	Current Price per COLL Share Held	Previous Price per COLL Share Held
2025-12-03 (Wednesday)	21,887	USD 1,047,293	USD 1,047,293	0	USD 7,442	USD 47.85	USD 47.51
2025-12-02 (Tuesday)	21,887	USD 1,039,851	USD 1,039,851	780	USD 50,777	USD 47.51	USD 46.86
2025-12-01 (Monday)	21,107	USD 989,074	USD 989,074	0	USD 3,799	USD 46.86	USD 46.68
2025-11-28 (Friday)	21,107	USD 985,275	USD 985,275	52	USD 11,902	USD 46.68	USD 46.23
2025-11-27 (Thursday)	21,055	USD 973,373	USD 973,373	0	USD 0	USD 46.23	USD 46.23
2025-11-26 (Wednesday)	21,055	USD 973,373	USD 973,373	156	USD 20,379	USD 46.23	USD 45.6
2025-11-25 (Tuesday)	20,899	USD 952,994	USD 952,994	260	USD 12,372	USD 45.6	USD 45.575
2025-11-24 (Monday)	20,639	USD 940,622	USD 940,622	52	USD 11,325	USD 45.575	USD 45.14
2025-11-21 (Friday)	20,587	USD 929,297	USD 929,297	0	USD 24,498	USD 45.14	USD 43.95
2025-11-20 (Thursday)	20,587	USD 904,799	USD 904,799	-208	USD -19,955	USD 43.95	USD 44.47
2025-11-19 (Wednesday)	20,795	USD 924,754	USD 924,754	52	USD -15,734	USD 44.47	USD 45.34
2025-11-18 (Tuesday)	20,743	USD 940,488	USD 940,488	312	USD 14,146	USD 45.34	USD 45.34
2025-11-17 (Monday)	20,431	USD 926,342	USD 926,342	104	USD -8,293	USD 45.34	USD 45.98

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of COLL by Blackrock for IE00BYXG2H39

Show aggregate share trades of COLL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 780 47.695 45.820 46.007 USD 35,886 32.27
2025-11-28 BUY 52 47.000 46.215 46.294 USD 2,407 32.13
2025-11-26 BUY 156 46.700 45.330 45.467 USD 7,093 32.00
2025-11-26 BUY 156 46.700 45.330 45.467 USD 7,093 32.00
2025-11-25 BUY 260 46.480 45.500 45.598 USD 11,855 31.93
2025-11-24 BUY 52 45.600 44.615 44.714 USD 2,325 31.87
2025-11-20 SELL -208 45.330 43.780 43.935 USD -9,138 31.75 Loss of -2,535 on sale
2025-11-19 BUY 52 45.859 44.400 44.546 USD 2,316 31.68
2025-11-18 BUY 312 46.050 44.490 44.646 USD 13,930 31.62
2025-11-17 BUY 104 46.480 43.590 43.879 USD 4,563 31.55
2025-11-14 BUY 52 46.260 45.452 45.533 USD 2,368 31.48
2025-11-12 BUY 52 47.500 45.000 45.250 USD 2,353 31.32
2025-11-10 BUY 52 43.680 41.980 42.150 USD 2,192 31.19
2025-11-06 BUY 52 41.810 39.080 39.353 USD 2,046 31.09
2025-11-04 BUY 52 36.540 35.620 35.712 USD 1,857 31.04
2025-10-30 BUY 260 35.760 33.890 34.077 USD 8,860 30.96
2025-10-29 BUY 104 34.810 35.900 35.791 USD 3,722 30.94
2025-10-22 SELL -208 35.710 35.915 35.895 USD -7,466 30.82 Loss of -1,055 on sale
2025-10-20 BUY 104 34.850 34.880 34.877 USD 3,627 30.78
2025-10-17 BUY 260 33.940 34.070 34.057 USD 8,855 30.76
2025-10-15 BUY 416 32.880 33.000 32.988 USD 13,723 30.75
2025-10-03 BUY 364 34.610 35.150 35.096 USD 12,775 30.72
2025-10-02 BUY 52 34.280 35.305 35.203 USD 1,831 30.70
2025-09-30 BUY 104 34.990 35.535 35.481 USD 3,690 30.65
2025-09-26 BUY 104 34.410 35.540 35.427 USD 3,684 30.60
2025-09-25 BUY 104 34.650 36.290 36.126 USD 3,757 30.58
2025-09-24 SELL -1,445 35.160 35.450 35.421 USD -51,183 30.55 Loss of -7,032 on sale
2025-09-18 BUY 56 36.160 36.260 36.250 USD 2,030 30.52
2025-09-17 BUY 171 35.540 36.565 36.462 USD 6,235 30.49
2025-08-20 SELL -224 38.370 38.490 38.478 USD -8,619 30.31 Loss of -1,830 on sale
2025-07-30 BUY 224 30.700 31.510 31.429 USD 7,040 30.13
2025-07-17 SELL -112 32.260 32.360 32.350 USD -3,623 30.04 Loss of -259 on sale
2025-07-11 SELL -448 32.520 33.010 32.961 USD -14,767 29.98 Loss of -1,338 on sale
2025-07-07 BUY 168 30.900 31.990 31.881 USD 5,356 29.92
2025-07-02 BUY 3,080 30.510 30.620 30.609 USD 94,276 29.91
2025-06-20 BUY 899 29.830 29.970 29.956 USD 26,930 29.91
2025-06-11 BUY 108 29.690 30.590 30.500 USD 3,294 29.93
2025-06-10 BUY 108 30.370 30.930 30.874 USD 3,334 29.93
2025-06-04 SELL -54 29.400 29.720 29.688 USD -1,603 29.93 Profit of 13 on sale
2025-04-23 BUY 53 25.990 27.477 27.328 USD 1,448 30.39
2025-04-10 SELL -424 24.670 25.990 25.858 USD -10,964 30.77 Profit of 2,083 on sale
2025-04-08 SELL -53 25.410 28.000 27.741 USD -1,470 30.88 Profit of 167 on sale
2025-04-07 SELL -53 27.380 28.365 28.266 USD -1,498 30.92 Profit of 141 on sale
2025-04-04 SELL -265 28.140 28.340 28.320 USD -7,505 30.96 Profit of 699 on sale
2025-04-01 BUY 974 29.390 30.525 30.411 USD 29,621 30.99
2025-03-31 SELL -153 29.850 30.200 30.165 USD -4,615 31.00 Profit of 128 on sale
2025-03-14 SELL -816 29.460 30.010 29.955 USD -24,443 31.17 Profit of 995 on sale
2025-03-07 SELL -102 28.910 30.010 29.900 USD -3,050 31.30 Profit of 143 on sale
2025-03-04 SELL -51 28.040 28.610 28.553 USD -1,456 31.42 Profit of 146 on sale
2025-02-25 BUY 102 28.820 29.400 29.342 USD 2,993 31.67
2025-02-19 SELL -51 29.910 30.385 30.338 USD -1,547 31.83 Profit of 76 on sale
2025-02-13 BUY 153 30.980 31.050 31.043 USD 4,750 31.97
2025-02-12 BUY 51 30.530 31.530 31.430 USD 1,603 32.00
2025-02-11 BUY 204 31.580 31.710 31.697 USD 6,466 32.01
2024-12-30 SELL -2,036 28.610 29.100 29.051 USD -59,148 32.30 Profit of 6,625 on sale
2024-11-18 SELL -840 29.220 29.780 29.724 USD -24,968 34.32 Profit of 3,860 on sale
2024-11-08 SELL -56 32.160 34.110 33.915 USD -1,899 34.68 Profit of 43 on sale
2024-10-21 SELL -57 36.460 38.515 38.309 USD -2,184 0.00 Loss of -2,184 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	780	47.695	45.820	46.007	USD 35,886	32.27
2025-11-28	BUY	52	47.000	46.215	46.294	USD 2,407	32.13
2025-11-26	BUY	156	46.700	45.330	45.467	USD 7,093	32.00
2025-11-26	BUY	156	46.700	45.330	45.467	USD 7,093	32.00
2025-11-25	BUY	260	46.480	45.500	45.598	USD 11,855	31.93
2025-11-24	BUY	52	45.600	44.615	44.714	USD 2,325	31.87
2025-11-20	SELL	-208	45.330	43.780	43.935	USD -9,138	31.75 Loss of -2,535 on sale
2025-11-19	BUY	52	45.859	44.400	44.546	USD 2,316	31.68
2025-11-18	BUY	312	46.050	44.490	44.646	USD 13,930	31.62
2025-11-17	BUY	104	46.480	43.590	43.879	USD 4,563	31.55
2025-11-14	BUY	52	46.260	45.452	45.533	USD 2,368	31.48
2025-11-12	BUY	52	47.500	45.000	45.250	USD 2,353	31.32
2025-11-10	BUY	52	43.680	41.980	42.150	USD 2,192	31.19
2025-11-06	BUY	52	41.810	39.080	39.353	USD 2,046	31.09
2025-11-04	BUY	52	36.540	35.620	35.712	USD 1,857	31.04
2025-10-30	BUY	260	35.760	33.890	34.077	USD 8,860	30.96
2025-10-29	BUY	104	34.810	35.900	35.791	USD 3,722	30.94
2025-10-22	SELL	-208	35.710	35.915	35.895	USD -7,466	30.82 Loss of -1,055 on sale
2025-10-20	BUY	104	34.850	34.880	34.877	USD 3,627	30.78
2025-10-17	BUY	260	33.940	34.070	34.057	USD 8,855	30.76
2025-10-15	BUY	416	32.880	33.000	32.988	USD 13,723	30.75
2025-10-03	BUY	364	34.610	35.150	35.096	USD 12,775	30.72
2025-10-02	BUY	52	34.280	35.305	35.203	USD 1,831	30.70
2025-09-30	BUY	104	34.990	35.535	35.481	USD 3,690	30.65
2025-09-26	BUY	104	34.410	35.540	35.427	USD 3,684	30.60
2025-09-25	BUY	104	34.650	36.290	36.126	USD 3,757	30.58
2025-09-24	SELL	-1,445	35.160	35.450	35.421	USD -51,183	30.55 Loss of -7,032 on sale
2025-09-18	BUY	56	36.160	36.260	36.250	USD 2,030	30.52
2025-09-17	BUY	171	35.540	36.565	36.462	USD 6,235	30.49
2025-08-20	SELL	-224	38.370	38.490	38.478	USD -8,619	30.31 Loss of -1,830 on sale
2025-07-30	BUY	224	30.700	31.510	31.429	USD 7,040	30.13
2025-07-17	SELL	-112	32.260	32.360	32.350	USD -3,623	30.04 Loss of -259 on sale
2025-07-11	SELL	-448	32.520	33.010	32.961	USD -14,767	29.98 Loss of -1,338 on sale
2025-07-07	BUY	168	30.900	31.990	31.881	USD 5,356	29.92
2025-07-02	BUY	3,080	30.510	30.620	30.609	USD 94,276	29.91
2025-06-20	BUY	899	29.830	29.970	29.956	USD 26,930	29.91
2025-06-11	BUY	108	29.690	30.590	30.500	USD 3,294	29.93
2025-06-10	BUY	108	30.370	30.930	30.874	USD 3,334	29.93
2025-06-04	SELL	-54	29.400	29.720	29.688	USD -1,603	29.93 Profit of 13 on sale
2025-04-23	BUY	53	25.990	27.477	27.328	USD 1,448	30.39
2025-04-10	SELL	-424	24.670	25.990	25.858	USD -10,964	30.77 Profit of 2,083 on sale
2025-04-08	SELL	-53	25.410	28.000	27.741	USD -1,470	30.88 Profit of 167 on sale
2025-04-07	SELL	-53	27.380	28.365	28.266	USD -1,498	30.92 Profit of 141 on sale
2025-04-04	SELL	-265	28.140	28.340	28.320	USD -7,505	30.96 Profit of 699 on sale
2025-04-01	BUY	974	29.390	30.525	30.411	USD 29,621	30.99
2025-03-31	SELL	-153	29.850	30.200	30.165	USD -4,615	31.00 Profit of 128 on sale
2025-03-14	SELL	-816	29.460	30.010	29.955	USD -24,443	31.17 Profit of 995 on sale
2025-03-07	SELL	-102	28.910	30.010	29.900	USD -3,050	31.30 Profit of 143 on sale
2025-03-04	SELL	-51	28.040	28.610	28.553	USD -1,456	31.42 Profit of 146 on sale
2025-02-25	BUY	102	28.820	29.400	29.342	USD 2,993	31.67
2025-02-19	SELL	-51	29.910	30.385	30.338	USD -1,547	31.83 Profit of 76 on sale
2025-02-13	BUY	153	30.980	31.050	31.043	USD 4,750	31.97
2025-02-12	BUY	51	30.530	31.530	31.430	USD 1,603	32.00
2025-02-11	BUY	204	31.580	31.710	31.697	USD 6,466	32.01
2024-12-30	SELL	-2,036	28.610	29.100	29.051	USD -59,148	32.30 Profit of 6,625 on sale
2024-11-18	SELL	-840	29.220	29.780	29.724	USD -24,968	34.32 Profit of 3,860 on sale
2024-11-08	SELL	-56	32.160	34.110	33.915	USD -1,899	34.68 Profit of 43 on sale
2024-10-21	SELL	-57	36.460	38.515	38.309	USD -2,184	0.00 Loss of -2,184 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of COLL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	61,020	0	88,706	68.8%
2025-09-18	41,541	0	67,794	61.3%
2025-09-17	66,618	0	114,347	58.3%
2025-09-16	133,161	0	194,298	68.5%
2025-09-15	152,551	0	212,478	71.8%
2025-09-12	95,136	0	129,598	73.4%
2025-09-11	110,423	0	246,764	44.7%
2025-09-10	53,467	0	99,007	54.0%
2025-09-09	109,513	0	233,493	46.9%
2025-09-08	206,377	2	311,091	66.3%
2025-09-05	78,137	0	150,749	51.8%
2025-09-04	64,006	6,972	105,811	60.5%
2025-09-03	63,593	0	122,600	51.9%
2025-09-02	101,085	0	159,730	63.3%
2025-08-29	46,433	0	126,235	36.8%
2025-08-28	51,923	0	97,387	53.3%
2025-08-27	31,315	0	75,370	41.5%
2025-08-26	40,930	0	153,664	26.6%
2025-08-25	56,670	0	122,837	46.1%
2025-08-22	35,563	0	123,465	28.8%
2025-08-21	36,265	0	85,499	42.4%
2025-08-20	49,364	15	88,020	56.1%
2025-08-19	63,109	50	120,936	52.2%
2025-08-18	29,505	0	92,255	32.0%
2025-08-15	20,662	0	64,211	32.2%
2025-08-14	87,424	0	118,481	73.8%
2025-08-13	49,958	14	132,123	37.8%
2025-08-12	91,824	0	151,451	60.6%
2025-08-11	129,883	3,211	250,035	51.9%
2025-08-08	83,394	0	319,663	26.1%
2025-08-07	193,676	0	339,687	57.0%
2025-08-06	98,233	0	169,420	58.0%
2025-08-05	32,115	0	70,967	45.3%
2025-08-04	36,300	0	70,243	51.7%
2025-08-01	102,275	0	172,380	59.3%
2025-07-31	35,405	0	66,557	53.2%
2025-07-30	21,992	0	61,112	36.0%
2025-07-29	26,689	0	72,676	36.7%
2025-07-28	22,692	0	82,913	27.4%
2025-07-25	30,500	0	69,126	44.1%
2025-07-24	26,485	0	68,767	38.5%
2025-07-23	24,505	0	67,625	36.2%
2025-07-22	41,446	1,004	84,381	49.1%
2025-07-21	32,627	0	70,693	46.2%
2025-07-18	26,588	14	56,895	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE